Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Downs Christopher buys 3,100 shares of CNS Pharmaceuticals, Inc. [CNSP]
By USInMinutes - Apr 18, 2023, 08:37 AM ET
Last Updated - Jul 18, 2023, 03:54 PM EDT
Transaction increases the holding of Downs Christopher in the company to 9,251
Downs Christopher has bought 3,100 shares of Cns Pharmaceuticals, Inc. [CNSP] at $3.20 a share.
Cns Pharmaceuticals, Inc. [CNSP] disclosed in an SEC Form 4 submission Monday, April 17, 2023 that the deal increased Downs Christopher's holding in the company to 9,251.
Cns Pharmaceuticals, Inc. [CNSP] is a Pharmaceutical Preparations company based in Nevada.
Also Read:
- Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
- CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
- CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight Event
- CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
- CNS Pharmaceuticals to Participate at the Virtual Investor "Ask the CEO" Event
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Although all care is taken to ensure the accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications.
Sponsored
Read More from USinMinutes
Popular News
Latest News